A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma [Corrigendum]
Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B. Cancer Manag Res. 2023;15:651–666. The authors have advised Table 2 on pages 654-656, is incorrect. The correct Table 2 is as follows. Table 2 Baseline characteristics of patients Page 663, Figure 6 caption, the text “(D) OS of B...
Main Authors: | Liu Y, Sheng L, Hua H, Zhou J, Zhao Y, Wang B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-09-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/corrigendum-a-novel-and-validated-inflammation-based-prognosis-score-i-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma
by: Liu Y, et al.
Published: (2023-07-01) -
A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma
by: Wang Z, et al.
Published: (2024-01-01) -
Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma
by: Hongyan Deng, et al.
Published: (2022-12-01) -
Cell of Origin Based on Hans’ Algorithm as Prognostic Factor in Diffuse Large B-Cell Lymphoma: A Clinicopathologic and Survival Study
by: Wiwiek Probowati, et al.
Published: (2022-03-01) -
Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
by: Bingxin Zhang, et al.
Published: (2023-01-01)